Effect of dietary vitamin E supplements on cholesteryl ester transfer activity in hamster adipose tissue

Atherosclerosis

Volumn 124, Issue 2, 1996, Pages 211-219

  Shen, Garry X ^a   Novak, Christopher ^a   Angel, Aubie ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Cholesteryl ester transfer activity; Hamsters; Lipoproteins; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL ESTER; LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; HAMSTER; INTRAGASTRIC DRUG ADMINISTRATION; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0030564991     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05827-3     Document Type: Article

References (42)

1. [1] Tall AR. Plasma lipid transfer proteins. Ann Rev Biochem 1995;64:235.
2. [2] Angel A, Fong B. Lipoprotein interaction and cholesterol metabolism in human fat cells, In: Angel A, Hollenberg CH, Roncari DAK. (eds). The Adipocyte and Obesity: Cellular and Molecular Mechanisms. New York: Raven Press, 1983;179.
3. [3] Fong BS, Rodrigue PO, Salter AM, Yip BP, Despres JP, Gregg RE, Angel A. Characterization of high density lipoprotein binding to human adipocyte plasma membranes. J Clin Invest 1985;75:1804.
4. [4] Quinet E, Tall A, Ramakrishnan R, Rudel L. Plasma lipid transfer protein as a determinant of the atherogenicity of monkey plasma lipoprotein. J Clin Invest 1991;87:1559.
5. [5] Drayna D, Jarnagin AS, McLean J, Henzel W, Kohr W, Fielding C, Lawn R. Cloning and sequencing of human cholesteryl ester transfer protein cDNA. Nature 1987;327:632.
6. [6] Jiang XC, Moulin P, Quinet E, Goldberg IJ, Yacoub LK, Agellon LB, Compton D, Schnitzer-Polokoff R, Tall AR. Mammalian adipose tissue and muscle are a major source of lipid transfer protein mRNA. J Biol Chem 1991;266:4631.
7. [7] Shen GX, Zhang JY, Blanchard R, Hayden M, McPherson R, Angel A. Analysis of cholesteryl ester transfer activity in adipose tissue. Int J Obes 1996;20:(S3):114.
8. [8] Shen GX, Angel A. Regulation of cholesteryl ester transfer activity in adipose tissue: A comparison between hamster and rat species. Am J Physiol 1995;269:E99.
9. [9] Burton GW, Ingold KU. Vitamin E as an in vitro and in vivo antioxidant. Ann NY Acad Sci 1989;570:7.
10. [10] Gey KF, Puska P, Jordan P, Moser U. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-culture epidemiology. Am J Clin Nutr 1987;53:326.
11. [11] Wilson RB, Middleton CC, Sun GY. Vitamin E, antioxidants and lipid peroxidation in experimental atherosclerosis of rabbits. J Nutr 1978;108:1858.
12. [12] Viswanathan M, Bhakthan NMG, Reckerbie RA. Effect of dietary supplementation on serum lipids and lipoproteins in rabbits fed a cholesterolemic diet. Int J Vit Nutr Res 1979;49:370.
13. [13] Komaratat P, Chupukcharoen N, Wilairat P. Effect of vitamin E on cholesterol plasma lipoprotein distribution and metabolism in rabbit. Int J Vit Nutr Res 1985;55:167.
14. [14] Wojcicki J, Rozewicka L, Barcew-Wiszniewska B, Samochowiec L, Juzwiak S, Kadlubowska D, Tustanowski S, Luzyszyn Z. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991;87:9.
15. [15] Prassad K, Kalra J. Oxygen free-radicals and hypercholesterolemic atherosclerosis: Effect of vitamin E. Am Heart J 1993;125:958.
16. [16] Hermann WJ Jr, Ward K, Faucett J. The effect of tocopherol on high density lipoprotein cholesterol. Am J Clin Pathol 1979;72:848.
17. [17] Hermann WJ Jr. The effect of vitamin E on lipoprotein cholesterol distribution. Ann NY Acad Sci 1982;393:467.
18. [18] Sundaram GS, London R, Manimekala S, Nair PP, Goldstein P. α-Tocopherol and serum lipoproteins. Lipids 1981;16:223.
19. [19] Barborak JJ, Ghaitit AZE, Shetty KR, Kalbfleisch JH. Vitamin E supplements and plasma high density lipoprotein cholesterol. Am J Clin Pathol 1982;77:371.
20. [20] Noma A, Maeda OM, Abe A, Muto Y. Reduction of serum lipoprotein(a) levels in hyperlipidaemic patients with α-tocopherol nicotinate. Atherosclerosis 1990;84:213.
21. [21] Schwartz PL, Rutherford IM. The effect of tocopherol on high density lipoprotein cholesterol. Am J Clin Pathol 1981;76:833.
22. [22] Kesaniemi YA, Grundy SM. Lack of effect of tocopherol on plasma lipids and lipoproteins in man. Am J Clin Nutr 1982;36:224.
23. [23] Ehncolm C, Huttunen JK, Kostianen E, Lukka M, Aho K. Vitamin E does not influence plasma lipoprotein metabolism in healthy subjects with normal nutritional status. Clin Chim Acta 1982;121:321.
24. [24] Howard PR, Rundell CA, Batsakis JG. Vitamin E does not modify HDL-cholesterol. Am J Clin Pathol 1982;77: 86.
25. [25] Bloster M, Cole M, Duggan PF, Crowley M. Lack of effect of ingestion of Vit.E on lipoprotein-cholesterol fractions in healthy adults. Irish Med J 1983;76:152.
26. [26] Stampfer MJ, Willett W, Castelli W, Taylor JO, Fine J, Hennekens CH. Effect of vitamin E on lipids. Am Clin Pathol 1983;79:714.
27. [27] Shen XY, Angel A. Identification of high density lipoprotein binding proteins in mature adipocyte plasma membranes. Biochem Cell Biol 1993;71:348.
28. [28] Schumaker VN, Puppione DL. Sequential floatation ultracentrifugation. Methods Enzymol 1986;128:155.
29. [29] Albers JJ, Tollefson JH, Chen CH, Steinmetz A. Isolation and characterization of human plasma lipid transfer proteins. Arteriosclerosis 1984;4:49.
30. [30] Morton RE, Zilversmit DB. The separation of apolipoprotein D from cholesteryl ester transfer protein. Biochim Biophys Acta 1981;663:350.
31. [31] Osborne JC. Delipidation of plasma lipoproteins. Methods Enzymol 1986;128:213.
32. [32] George R, Barber DL, Schneider WJ. Characterization of the chicken oocyte receptor for low and very low density lipoproteins. J Biol Chem 1987;262:16838.
33. [33] Friedewald WT, Levy RJ, Frederickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499.
34. [34] Bendich A, Machlin LJ. Safety of oral intake of vitamin E. Am J Clin Nutr 1988;48:612.
35. [35] Inazu A, Brown ML, Hesler CB, Agellon LB, Koizumi J, Takata K, Maruhamam Y, Tall AR. Increased high density lipoprotein levels caused by a common cholesteryl ester transfer protein gene mutation. N Engl J Med 1990;323:1234.
36. [36] Inazu A, Jiang XC, Haraki T, et al. Genetic cholesteryl ester transfer protein deficiency caused by two prevalent mutations as a major determinant of increased levels of high density lipoprotein cholesterol. J Clin Invest 1994;94:1872.
37. [37] Tall AR, Granot E, Brocia R, Tabas I, Hesler C, William K, Denke MA. Accelerated transfer of cholesteryl esters in dyslipidemic plasma: role of cholesteryl esters transfer protein. J Clin Invest 1987;79:1217.
38. [38] McPherson R, Mann CJ, Tall AR, Hogue M, Martin L, Milne RW, Marcel YL. Plasma concentration of cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991;11: 797.
39. [39] Bagdade JD, Ritter MC, Subbaiah PV. Accelerated cholesteryl ester transfer in plasma of patients with hypercholesterolemia. J Clin Invest 1991;87:1259.
40. [40] Inazu A, Koizumi J, Mabuchi H, Kajinami K, Takeda R. Enhanced cholesteryl ester transfer protein activities and abnormalities of high density lipoproteins in familial hypercholesterolemia. Hormone Metabol Res 1992;24: 284.
41. [41] Moulin P, Appel GB, Ginsberg HN, Tall AR. Increased concentration of plasma cholesteryl ester transfer protein in nephrotic syndrome: role in dyslipidemia. J Lipid Res 1992;33:1817.
42. [42] Dullart RPF, Gansevoort RT, Dikkeschei BD, De Zeeuw D, De Jong PE, van Tol A. Role of elevated lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein activities in abnormal lipoproteins from proteinuric patients. Kidney Int 1993;44:91.